Ingrid Theresa Katz, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 51 | 2024 | 17165 | 3.780 |
Why?
|
Anti-HIV Agents | 21 | 2024 | 4491 | 2.980 |
Why?
|
South Africa | 26 | 2024 | 1821 | 2.210 |
Why?
|
Papillomavirus Vaccines | 5 | 2020 | 495 | 1.700 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2020 | 1894 | 1.490 |
Why?
|
Anti-Retroviral Agents | 10 | 2024 | 1779 | 1.350 |
Why?
|
International Cooperation | 4 | 2023 | 1433 | 1.340 |
Why?
|
Acquired Immunodeficiency Syndrome | 6 | 2023 | 2197 | 1.310 |
Why?
|
Patient Acceptance of Health Care | 9 | 2020 | 3164 | 1.240 |
Why?
|
Social Stigma | 7 | 2020 | 734 | 1.140 |
Why?
|
Mass Vaccination | 2 | 2021 | 109 | 1.000 |
Why?
|
Transients and Migrants | 2 | 2024 | 162 | 0.950 |
Why?
|
Behavioral Sciences | 1 | 2023 | 29 | 0.910 |
Why?
|
Unemployment | 1 | 2024 | 209 | 0.840 |
Why?
|
Papillomavirus Infections | 4 | 2020 | 1607 | 0.820 |
Why?
|
Treatment Refusal | 2 | 2016 | 430 | 0.810 |
Why?
|
Medication Adherence | 8 | 2024 | 2165 | 0.790 |
Why?
|
Viral Load | 6 | 2019 | 3322 | 0.730 |
Why?
|
Attitude to Health | 4 | 2018 | 2029 | 0.710 |
Why?
|
Qualitative Research | 9 | 2024 | 2963 | 0.690 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2628 | 0.600 |
Why?
|
HIV Seropositivity | 2 | 2021 | 955 | 0.600 |
Why?
|
Pregnancy Complications, Infectious | 3 | 2015 | 2125 | 0.580 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2020 | 3986 | 0.570 |
Why?
|
Allied Health Personnel | 1 | 2018 | 156 | 0.540 |
Why?
|
Health Policy | 4 | 2021 | 2677 | 0.510 |
Why?
|
Caregivers | 4 | 2020 | 2224 | 0.510 |
Why?
|
HIV-1 | 8 | 2020 | 6849 | 0.490 |
Why?
|
Disease Transmission, Infectious | 2 | 2019 | 558 | 0.490 |
Why?
|
Africa South of the Sahara | 5 | 2022 | 742 | 0.490 |
Why?
|
Quarantine | 1 | 2016 | 176 | 0.460 |
Why?
|
Peer Group | 4 | 2023 | 674 | 0.450 |
Why?
|
Counseling | 5 | 2024 | 1548 | 0.450 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2017 | 791 | 0.440 |
Why?
|
Epidemics | 2 | 2019 | 510 | 0.430 |
Why?
|
Patient Care | 2 | 2022 | 624 | 0.430 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5325 | 0.420 |
Why?
|
Motivation | 2 | 2023 | 1993 | 0.420 |
Why?
|
Research Support as Topic | 1 | 2017 | 699 | 0.410 |
Why?
|
Social Support | 3 | 2019 | 2145 | 0.400 |
Why?
|
Decision Making | 3 | 2016 | 3925 | 0.400 |
Why?
|
Workload | 1 | 2018 | 847 | 0.390 |
Why?
|
HIV | 1 | 2019 | 1579 | 0.390 |
Why?
|
Resilience, Psychological | 1 | 2019 | 768 | 0.380 |
Why?
|
Patient Participation | 1 | 2020 | 1439 | 0.380 |
Why?
|
Trust | 1 | 2016 | 532 | 0.380 |
Why?
|
Psychotherapy, Group | 1 | 2015 | 410 | 0.380 |
Why?
|
Vaccination | 3 | 2020 | 3361 | 0.380 |
Why?
|
Uterine Cervical Neoplasms | 4 | 2018 | 2003 | 0.370 |
Why?
|
Public Health Administration | 1 | 2013 | 243 | 0.370 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2016 | 420 | 0.370 |
Why?
|
Health Services Accessibility | 5 | 2021 | 5397 | 0.370 |
Why?
|
Professional-Patient Relations | 1 | 2016 | 726 | 0.370 |
Why?
|
Uganda | 7 | 2024 | 1324 | 0.360 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 2010 | 39 | 0.360 |
Why?
|
Humans | 75 | 2024 | 760621 | 0.360 |
Why?
|
RNA, Viral | 3 | 2019 | 2838 | 0.350 |
Why?
|
Life Expectancy | 1 | 2017 | 1248 | 0.350 |
Why?
|
Developing Countries | 5 | 2020 | 2868 | 0.340 |
Why?
|
Disclosure | 1 | 2015 | 738 | 0.330 |
Why?
|
Burnout, Professional | 1 | 2018 | 702 | 0.320 |
Why?
|
Behavior, Addictive | 1 | 2014 | 462 | 0.320 |
Why?
|
Health Services Administration | 2 | 2020 | 63 | 0.310 |
Why?
|
Adolescent | 18 | 2024 | 87810 | 0.300 |
Why?
|
Chemoprevention | 1 | 2010 | 326 | 0.300 |
Why?
|
Developed Countries | 1 | 2010 | 442 | 0.290 |
Why?
|
Health Personnel | 2 | 2018 | 3310 | 0.290 |
Why?
|
Pandemics | 3 | 2024 | 8624 | 0.290 |
Why?
|
Circumcision, Male | 1 | 2008 | 148 | 0.290 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2015 | 1348 | 0.280 |
Why?
|
Adult | 35 | 2024 | 219994 | 0.280 |
Why?
|
Male | 37 | 2024 | 359744 | 0.270 |
Why?
|
CD4 Lymphocyte Count | 6 | 2020 | 2569 | 0.260 |
Why?
|
Female | 45 | 2024 | 391270 | 0.260 |
Why?
|
Tobacco Industry | 1 | 2007 | 135 | 0.260 |
Why?
|
Sexual Behavior | 3 | 2024 | 2086 | 0.250 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2005 | 102 | 0.250 |
Why?
|
Terminally Ill | 1 | 2007 | 240 | 0.250 |
Why?
|
Antitrust Laws | 1 | 2004 | 8 | 0.250 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4371 | 0.240 |
Why?
|
Nursing Care | 1 | 2005 | 65 | 0.240 |
Why?
|
Abortion, Legal | 1 | 2006 | 114 | 0.240 |
Why?
|
Marketing | 1 | 2007 | 220 | 0.240 |
Why?
|
Patient Satisfaction | 2 | 2015 | 3448 | 0.240 |
Why?
|
Medication Systems, Hospital | 1 | 2005 | 154 | 0.240 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2006 | 238 | 0.240 |
Why?
|
Young Adult | 14 | 2024 | 58741 | 0.230 |
Why?
|
Adolescent Behavior | 1 | 2012 | 1175 | 0.220 |
Why?
|
Relief Work | 1 | 2004 | 129 | 0.220 |
Why?
|
United States | 16 | 2023 | 72461 | 0.220 |
Why?
|
Physicians | 2 | 2018 | 4591 | 0.210 |
Why?
|
Sexual Partners | 2 | 2024 | 753 | 0.210 |
Why?
|
Personnel Selection | 1 | 2004 | 193 | 0.210 |
Why?
|
Salaries and Fringe Benefits | 1 | 2004 | 258 | 0.200 |
Why?
|
Interviews as Topic | 4 | 2024 | 2659 | 0.200 |
Why?
|
Biomedical Research | 1 | 2017 | 3426 | 0.190 |
Why?
|
History, 21st Century | 2 | 2023 | 1575 | 0.180 |
Why?
|
Viral Vaccines | 1 | 2006 | 596 | 0.180 |
Why?
|
Self Care | 1 | 2006 | 793 | 0.180 |
Why?
|
Culture | 2 | 2016 | 622 | 0.180 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7475 | 0.180 |
Why?
|
Africa | 2 | 2015 | 705 | 0.170 |
Why?
|
Hospice Care | 1 | 2007 | 692 | 0.170 |
Why?
|
Rural Population | 3 | 2018 | 2268 | 0.170 |
Why?
|
Papillomaviridae | 1 | 2006 | 1117 | 0.170 |
Why?
|
Kenya | 1 | 2022 | 749 | 0.170 |
Why?
|
Public Health | 2 | 2017 | 2653 | 0.170 |
Why?
|
Medication Errors | 1 | 2005 | 784 | 0.160 |
Why?
|
Logistic Models | 4 | 2019 | 13314 | 0.160 |
Why?
|
Self Concept | 1 | 2024 | 1039 | 0.160 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7806 | 0.150 |
Why?
|
Health Services | 2 | 2020 | 753 | 0.150 |
Why?
|
Government Programs | 1 | 2020 | 280 | 0.150 |
Why?
|
Cohort Studies | 6 | 2024 | 41335 | 0.150 |
Why?
|
Leadership | 2 | 2018 | 1371 | 0.150 |
Why?
|
Viremia | 1 | 2021 | 707 | 0.150 |
Why?
|
Colorado | 1 | 2018 | 164 | 0.150 |
Why?
|
Politics | 2 | 2020 | 814 | 0.150 |
Why?
|
Emigrants and Immigrants | 1 | 2024 | 539 | 0.140 |
Why?
|
Depressive Disorder, Major | 1 | 2015 | 4744 | 0.140 |
Why?
|
Focus Groups | 1 | 2022 | 1378 | 0.140 |
Why?
|
Brazil | 1 | 2020 | 1218 | 0.140 |
Why?
|
Pregnancy | 7 | 2019 | 29749 | 0.130 |
Why?
|
Asymptomatic Diseases | 1 | 2019 | 587 | 0.130 |
Why?
|
Community Health Services | 1 | 2020 | 654 | 0.130 |
Why?
|
Budgets | 1 | 2017 | 230 | 0.130 |
Why?
|
Continuity of Patient Care | 1 | 2022 | 1066 | 0.120 |
Why?
|
Efficiency | 1 | 2018 | 477 | 0.120 |
Why?
|
Public-Private Sector Partnerships | 1 | 2015 | 122 | 0.120 |
Why?
|
Science | 1 | 2017 | 239 | 0.120 |
Why?
|
Asymptomatic Infections | 1 | 2015 | 131 | 0.120 |
Why?
|
Community Health Centers | 1 | 2017 | 453 | 0.110 |
Why?
|
Homosexuality, Male | 1 | 2022 | 1273 | 0.110 |
Why?
|
Job Satisfaction | 1 | 2018 | 539 | 0.110 |
Why?
|
Intention | 1 | 2016 | 345 | 0.110 |
Why?
|
Efficiency, Organizational | 1 | 2018 | 697 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1201 | 0.110 |
Why?
|
Ciliary Motility Disorders | 1 | 1992 | 51 | 0.100 |
Why?
|
Pregnancy Trimester, Third | 1 | 2015 | 582 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1139 | 0.100 |
Why?
|
Social Isolation | 1 | 2015 | 362 | 0.100 |
Why?
|
Harm Reduction | 1 | 2013 | 145 | 0.100 |
Why?
|
Insurance Coverage | 2 | 2018 | 1939 | 0.100 |
Why?
|
Palliative Care | 1 | 2007 | 3607 | 0.100 |
Why?
|
Prospective Studies | 4 | 2021 | 54303 | 0.100 |
Why?
|
Acculturation | 1 | 2013 | 177 | 0.100 |
Why?
|
Parity | 1 | 2015 | 925 | 0.100 |
Why?
|
Tuberculosis | 1 | 2024 | 2001 | 0.090 |
Why?
|
Smoking | 1 | 2007 | 9073 | 0.090 |
Why?
|
Mental Health | 1 | 2024 | 3213 | 0.090 |
Why?
|
Mass Screening | 1 | 2006 | 5423 | 0.090 |
Why?
|
Child | 6 | 2020 | 79806 | 0.090 |
Why?
|
Middle Aged | 12 | 2020 | 220352 | 0.090 |
Why?
|
Sex Factors | 3 | 2019 | 10547 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4538 | 0.080 |
Why?
|
Truth Disclosure | 1 | 2013 | 432 | 0.080 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14495 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2018 | 1192 | 0.080 |
Why?
|
Nasal Mucosa | 1 | 1992 | 412 | 0.080 |
Why?
|
Sex Offenses | 1 | 2013 | 351 | 0.080 |
Why?
|
Odds Ratio | 1 | 2021 | 9716 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2024 | 4446 | 0.080 |
Why?
|
Patient Transfer | 1 | 2015 | 779 | 0.080 |
Why?
|
Family Characteristics | 1 | 2013 | 1001 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 40165 | 0.080 |
Why?
|
Sexually Transmitted Diseases | 1 | 2013 | 628 | 0.070 |
Why?
|
Parent-Child Relations | 1 | 2012 | 758 | 0.070 |
Why?
|
Oncogenes | 1 | 2013 | 1220 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8803 | 0.070 |
Why?
|
Health Plan Implementation | 1 | 2010 | 335 | 0.070 |
Why?
|
Patient Compliance | 1 | 2018 | 2688 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1830 | 0.070 |
Why?
|
Prenatal Care | 1 | 2015 | 1129 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2515 | 0.070 |
Why?
|
Respiratory Tract Diseases | 1 | 1992 | 748 | 0.070 |
Why?
|
Risk-Taking | 1 | 2012 | 998 | 0.070 |
Why?
|
Microtubules | 1 | 1992 | 1072 | 0.070 |
Why?
|
History, 20th Century | 2 | 2004 | 2773 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2511 | 0.070 |
Why?
|
Product Labeling | 1 | 2007 | 77 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 25942 | 0.070 |
Why?
|
Computer User Training | 1 | 2005 | 19 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2020 | 2557 | 0.060 |
Why?
|
Education, Nursing, Continuing | 1 | 2005 | 70 | 0.060 |
Why?
|
Program Evaluation | 2 | 2024 | 2493 | 0.060 |
Why?
|
Afghanistan | 1 | 2004 | 79 | 0.060 |
Why?
|
Iraq | 1 | 2004 | 94 | 0.060 |
Why?
|
Hospitals, Military | 1 | 2004 | 62 | 0.060 |
Why?
|
Taxes | 1 | 2007 | 222 | 0.060 |
Why?
|
Supreme Court Decisions | 1 | 2006 | 133 | 0.060 |
Why?
|
Depression | 1 | 2024 | 8044 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2622 | 0.060 |
Why?
|
Internship and Residency | 1 | 2004 | 5870 | 0.060 |
Why?
|
Device Approval | 1 | 2006 | 165 | 0.060 |
Why?
|
Mortality | 1 | 2015 | 2916 | 0.060 |
Why?
|
Organizations | 1 | 2004 | 171 | 0.060 |
Why?
|
Health Education | 1 | 2010 | 1049 | 0.060 |
Why?
|
Risk Factors | 5 | 2016 | 74359 | 0.060 |
Why?
|
False Positive Reactions | 1 | 2006 | 956 | 0.050 |
Why?
|
Parents | 1 | 2017 | 3549 | 0.050 |
Why?
|
Vaginal Smears | 1 | 2006 | 495 | 0.050 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4013 | 0.050 |
Why?
|
Hospital Information Systems | 1 | 2005 | 394 | 0.050 |
Why?
|
Dilatation and Curettage | 1 | 2002 | 52 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2016 | 3865 | 0.050 |
Why?
|
Mental Disorders | 1 | 2022 | 6796 | 0.050 |
Why?
|
Homicide | 1 | 2004 | 295 | 0.050 |
Why?
|
Commerce | 1 | 2007 | 605 | 0.050 |
Why?
|
Internationality | 1 | 2007 | 1004 | 0.050 |
Why?
|
Saliva | 1 | 2006 | 820 | 0.050 |
Why?
|
Pregnancy, Ectopic | 1 | 2002 | 143 | 0.050 |
Why?
|
World Health Organization | 1 | 2007 | 1312 | 0.050 |
Why?
|
Primary Prevention | 1 | 2008 | 1207 | 0.050 |
Why?
|
Insurance, Health | 2 | 2018 | 2501 | 0.050 |
Why?
|
China | 1 | 2007 | 2339 | 0.050 |
Why?
|
Terminal Care | 1 | 2013 | 1758 | 0.050 |
Why?
|
Abortion, Induced | 1 | 2006 | 460 | 0.040 |
Why?
|
SEER Program | 2 | 2018 | 1530 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2018 | 4775 | 0.040 |
Why?
|
Preventive Health Services | 1 | 2004 | 570 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2017 | 80372 | 0.040 |
Why?
|
HIV Antibodies | 1 | 2006 | 1300 | 0.040 |
Why?
|
Health Expenditures | 2 | 2022 | 2362 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4024 | 0.040 |
Why?
|
Maternal Mortality | 1 | 2020 | 300 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2019 | 418 | 0.040 |
Why?
|
Abortion, Spontaneous | 1 | 2002 | 530 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15687 | 0.040 |
Why?
|
Medicare | 2 | 2022 | 6786 | 0.030 |
Why?
|
State Government | 1 | 2019 | 380 | 0.030 |
Why?
|
Private Sector | 1 | 2020 | 397 | 0.030 |
Why?
|
Women's Health | 1 | 2006 | 2056 | 0.030 |
Why?
|
Regression Analysis | 2 | 2017 | 6360 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6315 | 0.030 |
Why?
|
California | 1 | 2019 | 1416 | 0.030 |
Why?
|
Government Regulation | 1 | 2020 | 525 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2002 | 1745 | 0.030 |
Why?
|
Psychology | 1 | 2016 | 355 | 0.030 |
Why?
|
Pregnant Women | 1 | 2019 | 563 | 0.030 |
Why?
|
Drug Combinations | 1 | 2019 | 2025 | 0.030 |
Why?
|
Length of Stay | 1 | 2007 | 6479 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 533 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12531 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2006 | 14660 | 0.030 |
Why?
|
India | 1 | 2020 | 2336 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 160 | 0.030 |
Why?
|
Cilia | 2 | 1992 | 493 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 65017 | 0.020 |
Why?
|
Aged | 4 | 2022 | 169152 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2010 | 26181 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3215 | 0.020 |
Why?
|
Kartagener Syndrome | 1 | 1989 | 33 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 895 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29932 | 0.020 |
Why?
|
Fallopian Tubes | 1 | 1989 | 178 | 0.020 |
Why?
|
Infant | 1 | 2010 | 36060 | 0.020 |
Why?
|
Poverty | 1 | 2020 | 2695 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3615 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 13308 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2435 | 0.020 |
Why?
|
Respiratory System | 1 | 1989 | 557 | 0.020 |
Why?
|
Patient Preference | 1 | 2013 | 922 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2017 | 3562 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4283 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4107 | 0.020 |
Why?
|
Neoplasms | 1 | 2013 | 22072 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2013 | 2864 | 0.010 |
Why?
|
Infertility, Female | 1 | 1989 | 759 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18416 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2018 | 3388 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13502 | 0.010 |
Why?
|
Chorionic Gonadotropin | 1 | 2002 | 457 | 0.010 |
Why?
|
Models, Statistical | 1 | 2014 | 5075 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10756 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2013 | 3242 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12960 | 0.010 |
Why?
|
Pregnancy Trimester, First | 1 | 2002 | 908 | 0.010 |
Why?
|
Chronic Disease | 1 | 1992 | 9287 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2475 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20080 | 0.010 |
Why?
|
Child, Preschool | 1 | 1992 | 42063 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2002 | 15289 | 0.000 |
Why?
|
Epithelium | 1 | 1989 | 1605 | 0.000 |
Why?
|